-
Noubar Afeyan also reiterated a pledge Moderna made a year ago not to enforce patent infringement on anyone else making a coronavirus vaccine during the pandemic.
-
How much the vaccine manufacturers stand to gain depends on how big the rollout proves to be.
-
But the researchers stressed that all three vaccines, including the Pfizer and Johnson & Johnson shots, provide strong protection against people getting so sick that they end up in the hospital.
-
Moderna submitted data from 344 volunteers who got a third shot of the vaccine six months after their first two doses. The additional shot significantly boosted immunity, the company said.
-
People with weakened immune systems who already got two doses of the Pfizer or Moderna COVID-19 vaccines can now get a third shot. But exactly who is eligible? Here's what we know so far.
-
The CDC is officially recommending a third dose of the Pfizer or Moderna vaccine for people with weakened immune systems. It follows the FDA authorization a day earlier.
-
Researchers are seeking volunteers in the Tampa region to participate in the study to evaluate safety and immune responses. Enrollment will begin in the coming days.
-
The delta variant is the fast-moving strain of the coronavirus now found in 96 countries. It's expected to be the dominant variant in the U.S. within weeks.
-
Company officials intend to submit its teen data to the Food and Drug Administration and other global regulators early next month.
-
President Biden's commitment Monday to donate doses of Moderna, Pfizer and Johnson & Johnson vaccines adds to an earlier promise of 60 million doses of AstraZeneca.